Pharmabiz

WHO launches new country guidance for health emergency coordination

WHO launches new country guidance for health emergency coordination: Geneva Saturday, October 25, 2025, 16:00 Hrs [IST] The World Health Organization (WHO) has released a comprehe ...
Pharmabiz

Secarna Pharma inks agreement with Scenic Biotech to discover and co-develop disease-modifying oligonucleotide therapy against a novel drug target

Secarna Pharma inks agreement with Scenic Biotech to discover and co-develop disease-modifying oligonucleotide therapy against a novel drug target: Munich, Germany Saturday, Octob ...
Pharmabiz

BridgeBio Oncology announces new preclinical data of BBO-11818 demonstrating its potential as a potent panKRAS inhibitor targeting mutant KRAS

South San Francisco, California Saturday, October 25, 2025, 14:00 Hrs [IST] ...
Pharmabiz

CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment

CAGE Bio begins double-blind placebo-controlled clinical trial of topical DNA Aptamer therapy CGB-600 for vitiligo treatment: San Carlos, California Saturday, October 25, 2025, 12 ...
Pharmabiz

US FDA publishes filing checklists to prevent submission delays

US FDA publishes filing checklists to prevent submission delays: Maryland Saturday, October 25, 2025, 13:00 Hrs [IST] The US Food and Drug Administration (FDA) made public filing ...
Pharmabiz

MERS-CoV virus isolate added to the WHO BioHub System, enabling further research and pandemic preparedness

MERS-CoV virus isolate added to the WHO BioHub System, enabling further research and pandemic preparedness: Geneva Saturday, October 25, 2025, 10:00 Hrs [IST] An isolate of Middle ...
Pharmabiz

FICCI envisages it's Smart AAMs initiative to strengthen primary healthcare

FICCI envisages it's Smart AAMs initiative to strengthen primary healthcare: Our Bureau, New Delhi Saturday, October 25, 2025, 09:30 Hrs [IST] In line with the Central Government' ...
Pharmabiz

GSK’s Blenrep receives US FDA approval to treat relapsed/refractory multiple myeloma

GSK’s Blenrep receives US FDA approval to treat relapsed/refractory multiple myeloma: London, UK Saturday, October 25, 2025, 11:00 Hrs [IST] GSK plc announced the US Food and Dr ...
Pharmabiz

Chugai Pharma to acquire Tokyo-based clinical biopharmaceutical company, Renalys Pharma

Chugai Pharma to acquire Tokyo-based clinical biopharmaceutical company, Renalys Pharma: Tokyo, Japan Saturday, October 25, 2025, 09:00 Hrs [IST] Renalys Pharma, Inc., a privately ...
Pharmabiz

Healthcare sector stresses on evidence-based methods as several systemic issues hinder patient outcomes

Healthcare sector stresses on evidence-based methods as several systemic issues hinder patient outcomes: Nandita Vijayasimha, Bengaluru Saturday, October 25, 2025, 08:00 Hrs [IST] ...
Pharmabiz

Pharmexcil seeks suggestions on regulatory gap in new drug approvals identified by the CDSCO

Pharmexcil seeks suggestions on regulatory gap in new drug approvals identified by the CDSCO: Shardul Nautiyal, Mumbai Saturday, October 25, 2025, 08:00 Hrs [IST] The Pharmaceutic ...
Pharmabiz

IPA & KDPMA to hold workshop on BA/BE on November 22 in Bengaluru

IPA & KDPMA to hold workshop on BA/BE on November 22 in Bengaluru: Nandita Vijayasimha, Bengaluru Saturday, October 25, 2025, 08:00 Hrs [IST] The Indian Pharmaceutical Association ...